NatWest Group’s Dr. Reddy's Laboratories RDY Stock Holding History

NatWest Group’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-590,330	Closed	-$7.55M	–	291
2015 Q3	$7.55M	Buy	590,330 +29,265	+5%	+$364K	0.17%	80
2015 Q2	$6.21M	Sell	561,065 -29,265	-5%	-$323K	0.08%	92
2015 Q1	$6.74M	Sell	590,330 -78,395	-12%	-$832K	0.09%	98
2014 Q4	$6.75M	Sell	668,725 -62,020	-8%	-$653K	0.06%	96
2014 Q3	$7.68M	Sell	730,745 -41,930	-5%	-$394K	0.07%	107
2014 Q2	$6.67M	Buy	+772,675	New	+$6.5M	0.28%	109

Other funds holding RDY

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $355M AUM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VAM

Vontobel Asset Management New York $18.1B AUM 28.09% 1-Year Est. Return

BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

NatWest Group's RDY Position: Q4 2015 in Review

NatWest Group sold out of Dr. Reddy's Laboratories (RDY) in Q4 2015, closing a stake of 590,330 shares — an estimated $7.55M sold.

NatWest Group first reported a position in RDY in Q2 2014 and held it in 6 quarters. The position peaked at $7.68M in Q3 2014. 174 funds tracked by Wall St. Rank hold RDY as of Q4 2015.

NatWest Group reported no remaining Dr. Reddy's Laboratories position as of Q4 2015 after selling out during the quarter.
NatWest Group sold 590,330 Dr. Reddy's Laboratories shares in Q4 2015, an estimated $7.55M.
NatWest Group first reported a position in Dr. Reddy's Laboratories in Q2 2014 and held it in 6 quarters.
NatWest Group's Dr. Reddy's Laboratories position peaked at $7.68M in Q3 2014.
174 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q4 2015.

Based on NatWest Group's 13F filing for Q4 2015, filed 16 Feb 2016.